Literature DB >> 2494379

Role of phospholipase A in multiorgan failure with special reference to ARDS and acute renal failure (ARF).

M Baur1, T O Schmid, B Landauer.   

Abstract

In 150 patients admitted to an ICU phospholipase A serum activity was measured daily. The correlation between the increase of phospholipase A serum activity and the severity of adult respiratory distress syndrome (ARDS) and the incidence of acute renal failure (ARF), two important target systems in multiple organ failure (MOF) syndrome was studied as well as the efficacy of a treatment with phospholipase A inhibitors (methylprednisolone and dexamethasone). The results of this study show that there exists a statistically significant correlation between the increase of phospholipase A activity and the incidence of multiple organ failure. Inhibitory treatment ameliorates the organ function for a short time without any change of long-term outcome. The results could not clarify whether the rise of the mother enzyme of the arachidonic acid metabolism is only an epiphenomenon of multiple organ failure or the causative agent itself.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494379     DOI: 10.1007/bf01711353

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  5 in total

1.  Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation.

Authors:  R J Flower; G J Blackwell
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

Review 2.  Prostaglandin and thromboxane mediation of cardiopulmonary failure.

Authors:  H B Hechtman; W V Huval; M A Mathieson; L I Stemp; C R Valeri; D Shepro
Journal:  Surg Clin North Am       Date:  1983-04       Impact factor: 2.741

3.  Leukotrienes as mediators of skin inflammation.

Authors:  A W Ford-Hutchinson; A Rackman
Journal:  Br J Dermatol       Date:  1983-07       Impact factor: 9.302

4.  Thromboxane and prostacyclin in clinical acute respiratory failure.

Authors:  G J Slotman; K W Burchard; D S Gann
Journal:  J Surg Res       Date:  1985-07       Impact factor: 2.192

5.  Multiple organ failure in polytrauma patients.

Authors:  E Faist; A E Baue; H Dittmer; G Heberer
Journal:  J Trauma       Date:  1983-09
  5 in total
  6 in total

1.  Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE).

Authors:  Lori Styles; Carrie G Wager; Richard J Labotka; Kim Smith-Whitley; Alexis A Thompson; Peter A Lane; Lillian E C McMahon; Robin Miller; Susan D Roseff; Rathi V Iyer; Lewis L Hsu; Oswaldo L Castro; Kenneth I Ataga; Onyinye Onyekwere; Maureen Okam; Rita Bellevue; Scott T Miller
Journal:  Br J Haematol       Date:  2012-03-30       Impact factor: 6.998

2.  Platelet-activating factor and phospholipase A2 in patients with septic shock and trauma.

Authors:  J Sörensen; B Kald; C Tagesson; M Lindahl
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

3.  Elevation of serum phospholipase A2 in patients at an intensive care unit.

Authors:  M Kitagawa; T Hayakawa; T Kondo; T Shibata; Y Sakai; H Sobajima; H Ishiguro; M Tanikawa; Y Nakae; S Kameya
Journal:  Int J Pancreatol       Date:  1991 Nov-Dec

4.  Selective inhibition of group II phospholipase A2 by quercetin.

Authors:  M Lindahl; C Tagesson
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

5.  Urinary phospholipase A2 excretion in chronic pancreatic diseases.

Authors:  C Fabris; D Basso; M P Panozzo; G Del Favero; T Meggiato; M Plebani; C Ferrara; P Fogar; M Zaninotto; R Naccarato
Journal:  Int J Pancreatol       Date:  1992-06

Review 6.  The role of group IIA secretory phospholipase A2 (sPLA2-IIA) as a biomarker for the diagnosis of sepsis and bacterial infection in adults-A systematic review.

Authors:  Toh Leong Tan; Yew Yip Goh
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.